Skip to content
Open access

Multi-model Segmentation and Morphometric Quantification of Cerebral Amyloid Angiopathy in Alzheimer’s Disease Whole Slide Histopathology Images

Jul 2026 · bioRxiv · 0 citations · 54 references
Biology

TL;DR

A scalable, interpretable solution for vessel-level CAA analysis is provided, supporting robust geometric and spatial characterization of cerebrovascular pathology and enabling future integration with clinical and genetic studies.

Abstract

Introduction Cerebral amyloid angiopathy (CAA) is characterized by amyloid-beta deposition in cortical and leptomeningeal vessels and associated with cognitive impairment and hemorrhage. Current neuropathological assessments rely on semiquantitative grading and lack vessel-level resolution and scalability. Existing computational pathology approaches also fail to capture individual vessel morphology and spatial amyloid distribution across whole-slide images (WSIs). To address this gap, we developed a deep learning framework for reproducible, quantitative analysis of CAA in WSIs. Methods We analyzed 20 postmortem brain tissue sections from the frontal (n = 10) and occipital cortices (n = 10) of 10 individuals with Alzheimer’s disease pathology obtained from the University of Pittsburgh Alzheimer’s Disease Research Center, which served as the internal development cohort. An independent external cohort consisted of 10 sections (5 frontal and 5 occipital samples) from 5 individuals obtained from the University of Kentucky Alzheimer’s Disease Research Center. We trained and compared three semantic segmentation architectures, a standard U-Net, a dual-attention residual U-Net (DA-ResUNet), and a Swin Transformer-based U-Net (Swin-UNet), using the internal development cohort with slide-level five-fold cross-validation. All models were evaluated on the independent external cohort to assess generalization under domain shift. Based on segmentation performance and computational efficiency, we selected one architecture to generate whole-slide composite segmentation masks for vessel walls, amyloid deposits, and tissue compartments. These masks were subsequently used for deterministic vessel detection, morphometric measurements, and quantification of vascular and perivascular amyloid features through post-processing analysis. Results All three architectures achieved high segmentation accuracy on the internal cohort, with Dice scores above 90% across vessel walls, amyloid deposits, gray matter, and leptomeninges. The Swin-UNet showed marginally higher performance for vessel segmentation, whereas the DA-ResUNet provided more balanced accuracy and computational efficiency and was selected for downstream analysis. External cohort evaluation demonstrated robust generalization, with attention-enhanced models outperforming the standard U-Net under domain shift. Using the selected model, the pipeline reliably detected valid vessels, excluded non-vascular artifacts, and enabled deterministic extraction of vessel morphometry, vascular and perivascular amyloid burden, and identification of circumferential CAA involvement at the vessel level. Discussion This framework provides a scalable, interpretable solution for vessel-level CAA analysis, supporting robust geometric and spatial characterization of cerebrovascular pathology and enabling future integration with clinical and genetic studies. Beyond CAA, the modular design allows extension to other vascular pathologies, including arteriolosclerosis, in WSIs, facilitating broader investigation of cerebrovascular disease mechanisms.

Read PDF

Similar papers

Open access Aug 2026

White Matter and Perivascular Imaging Changes in Alzheimer's Disease and Cerebral Amyloid Angiopathy

Global and occipital PSMD may help identify AD participants with concomitant cerebral amyloid angiopathy (CAA) and DTI‐ALPS indices were associated with preserved language function and memory, and no PSMD metric was associated with any clinical measure.

Debina Laishram, G. Du, Sangam Kanekar et al. · 0 citations
Open access Sep 2026

Advanced quantitative mapping of Alzheimer’s disease neuropathology and microglial activation in post-mortem hippocampal tissue

A high-throughput imaging workflow to spatially map Alzheimer's disease pathology in postmortem hippocampal and medial temporal lobe sections reveals region- and sex-specific patterns of pathology and neuro inflammation, offering new insights into mechanisms driving cognitive decline and informing future diagnostic and...

T. Stephen, L. Korobkova, Kenneth Nguyen et al. · 0 citations
#protein folding Open access Aug 2026

Learning precise segmentation of neurofibrillary tangles from rapid manual point annotations

A scalable, open-source, deep-learning approach to quantify NFT burden in digital whole slide images (WSIs) of post-mortem human brain tissue and openly releases this multi-institution deep-learning pipeline to provide detailed NFT spatial distribution and morphology analysis capability at a scale otherwise infeasible...

S. Ghandian, Liane Albarghouthi, Kiana Nava et al. · 0 citations
Open access Aug 2026

An analysis of cerebral amyloid angiopathy based on samples from human brain bank

CAA is not simply an independent cerebrovascular disorder but also serves as a critical synergistic risk factor for Alzheimer’s disease neuropathologic change (ADNC) progression.

Yi-Zhou Zhang, Meng-Yao Ye, Shixiong Mi et al. · 0 citations
Open access Aug 2026

Region-specific cerebral blood flow differentiates cognitively impaired and unimpaired individuals with core Alzheimer's disease pathology

MRI measures of cerebral blood flow and white matter hyperintensities differentiated NDAN from AD+MCI, highlighting vascular contributions to cognitive resilience, and CBF differentiated AD+MCI from Controls.

S. Fernandes‐Taylor, I. Driscoll, M. Glittenberg et al. · 0 citations
Open access Sep 2026

A validated deep learning workflow for 3D quantification of amyloid plaques in cleared mouse brain.

A validated and scalable 3D analysis pipeline for whole-brain quantification of amyloid plaques in cleared mouse brain tissue imaged by light-sheet microscopy is presented, providing a platform for neuropathological phenotyping and therapeutic evaluation in preclinical AD research.

V. Valova, Louise Cole, N. Rodriguez et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.